Joong Kyong Ahn1, Sooah Kim2, Jiwon Hwang3, Jungyeon Kim2, Kyoung Heon Kim4, Hoon-Suk Cha5. 1. Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea. 2. Department of Biotechnology, Graduate School, Korea University, Seoul 02841, Republic of Korea. 3. Department of Internal Medicine, National Police Hospital, Seoul 05715, Republic of Korea. 4. Department of Biotechnology, Graduate School, Korea University, Seoul 02841, Republic of Korea. Electronic address: khekim@korea.ac.kr. 5. Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06531, Republic of Korea. Electronic address: hoonsuk.cha@samsung.com.
Abstract
OBJECTIVES: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by synovial inflammation and hyperplasia. Fibroblast-like synoviocytes (FLS) in RA exhibit a tumor cell-like aggressive phenotype. Thus, gas chromatography/time-of-flight-mass spectrometry (GC/TOF-MS) was employed to identify the characteristic metabolic profiling of RA FLS. METHODS: Metabolite profiling of RA FLS and osteoarthritis (OA) FLS was performed using GC/TOF-MS in conjunction with statistical analyses. We performed metabolite set enrichment analysis to establish which pathways are affected. RESULTS: A total of 129 metabolites were identified. A principal component analysis and hierarchical clustering analysis demonstrated clear differentiation of the metabolic profiling between RA FLS and OA FLS. The levels of 35 metabolites that belonged to the amines, fatty acids, phosphates, and organic acids class were significantly increased in RA FLS compared to those in OA FLS. Also, the levels of 26 metabolites that belonged to the amino acids, sugars, and sugar alcohols class were significantly decreased in RA FLS compared to those in OA FLS. The sugar metabolism (glycolysis and pentose phosphate pathway) and amino acid metabolism (tyrosine and catecholamine biosynthesis, and protein biosynthesis) were severely disturbed in RA FLS compared to those in OA FLS. CONCLUSIONS: Our metabolic results suggested that the alteration of sugar metabolism, lipolysis, and amino acid metabolism in RA FLS is related to synovial hyperplasia and inflammation. This is the first metabolomic study to determine metabolic changes characteristic of RA FLS, which will provide valuable information to gain in-depth insights into the pathogenesis of RA.
OBJECTIVES:Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by synovial inflammation and hyperplasia. Fibroblast-like synoviocytes (FLS) in RA exhibit a tumor cell-like aggressive phenotype. Thus, gas chromatography/time-of-flight-mass spectrometry (GC/TOF-MS) was employed to identify the characteristic metabolic profiling of RA FLS. METHODS: Metabolite profiling of RA FLS and osteoarthritis (OA) FLS was performed using GC/TOF-MS in conjunction with statistical analyses. We performed metabolite set enrichment analysis to establish which pathways are affected. RESULTS: A total of 129 metabolites were identified. A principal component analysis and hierarchical clustering analysis demonstrated clear differentiation of the metabolic profiling between RA FLS and OA FLS. The levels of 35 metabolites that belonged to the amines, fatty acids, phosphates, and organic acids class were significantly increased in RA FLS compared to those in OA FLS. Also, the levels of 26 metabolites that belonged to the amino acids, sugars, and sugar alcohols class were significantly decreased in RA FLS compared to those in OA FLS. The sugar metabolism (glycolysis and pentose phosphate pathway) and amino acid metabolism (tyrosine and catecholamine biosynthesis, and protein biosynthesis) were severely disturbed in RA FLS compared to those in OA FLS. CONCLUSIONS: Our metabolic results suggested that the alteration of sugar metabolism, lipolysis, and amino acid metabolism in RA FLS is related to synovial hyperplasia and inflammation. This is the first metabolomic study to determine metabolic changes characteristic of RA FLS, which will provide valuable information to gain in-depth insights into the pathogenesis of RA.
Authors: Jane Falconer; Anne N Murphy; Stephen P Young; Andrew R Clark; Stefano Tiziani; Monica Guma; Christopher D Buckley Journal: Arthritis Rheumatol Date: 2018-06-04 Impact factor: 10.995
Authors: Inkyung Kang; Christian Hundhausen; Stephen P Evanko; Prasanthi Malapati; Gail Workman; Christina K Chan; Cliff Rims; Gary S Firestein; David L Boyle; Kevin M MacDonald; Jane H Buckner; Thomas N Wight Journal: Matrix Biol Plus Date: 2022-04-26
Authors: Pablo Alarcon; Alejandra I Hidalgo; Carolina Manosalva; Raul Cristi; Stefanie Teuber; Maria A Hidalgo; Rafael A Burgos Journal: Sci Rep Date: 2019-04-01 Impact factor: 4.379
Authors: Marta F Bustamante; Ricard Garcia-Carbonell; Katrijn D Whisenant; Monica Guma Journal: Arthritis Res Ther Date: 2017-05-31 Impact factor: 5.156